The news comes on the heels of stories suggesting that PatientsLikeMe was seeking a new buyer due to concerns of foreign investment and influence.
The multi-year deal involves the two companies working together to engage patients and caregivers at every stage of their journey.
The new information highlights the reasons why patients use specific prescription drugs and how effective they think they are...
Together with NQF, PatientsLikeMe will work to develop, test and facilitate the broader use of PROMs to assess patient-reported health status.
The partnership will encourage people living with diabetes to offer perspectives to enhance and accelerate the registry's research and development agenda.
The FDA will get access to PatientsLikeMe's 110,000 adverse event reports on 1,000 different medications will be used as a supplement to traditional sources.
The content will be available from Partners Patient Gateway for patients to learn more about their condition and communicate with their doctors' offices.
AstraZeneca wants to use patient-reported data from PatientsLikeMe to shape future medicine development and help improve outcomes across therapeutic areas.
Users researching a medication on Walgreens.com can access a snapshot that shows how their prescribed medication has impacted other patients on the therapy.